Polymorphisms in CLOCK and ARNTL/BMAL-1 genes in multiple sclerosis: a systematic review and meta-analysis
Abstract
Background: Multiple sclerosis (MS) is still under investigation for its pathogenesis. This study explores the relationship between the key circadian rhythm regulators' genes, ARNTL/BMAL-1 and CLOCK, and MS pathogenesis.
Methods: Following the PRISMA2020 statement, a systematic search was conducted in PubMed, Scopus, Embase, and Web of Science for studies published up to July 2024. Clinical studies concerning the role of circadian genes in MS pathogenesis were considered for inclusion. The risk of bias was assessed using the JBI critical appraisal tools, and Comprehensive Meta-Analysis (CMA4) was utilized for the quantitative synthesis.
Result: Out of 537 results of the database searches, four studies were included. The total sample size of the included studies was 4010 (2110 MS cases and 1900 controls). CT genotype in rs6811520 in the CLOCK gene is suggested as a risk factor for MS in the Iranian population; however, there was no noteworthy association with rs3789327 in the ARNTL/BMAL-1 gene in this population. In individuals of Slavic origin, the CC genotype in both rs3789327 in the ARNTL/BMAL-1 gene and rs6811520 in the CLOCK gene was reported as a genetic risk factor for MS. In contrast, there was no association between MS status and genotypes of rs3789327 in the ARNTL/BMAL-1 gene and rs6811520 in the CLOCK gene in Caucasians of Spanish origin. In the Egyptian population, a higher prevalence of the TT genotype in MS patients was found in rs6811520 in the CLOCK gene. In…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Evaluating the Evidence Base of Melatonin, Light Exposure, Exercise, and Complementary and Alternative Medicine for Patients with Insomnia Disorder
- Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis
- Influence of evening light exposure on polysomnographically assessed night-time sleep: A systematic review with meta-analysis
- Use of melatonin in children and adolescents with idiopathic chronic insomnia: a systematic review, meta-analysis, and clinical recommendation
- Significant potential of melatonin therapy in Parkinson’s disease – a meta-analysis of randomized controlled trials
- Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.